Exchange Traded Concepts, LLC Rhythm Pharmaceuticals, Inc. Transaction History
Exchange Traded Concepts, LLC
- $5.43 Billion
- Q1 2025
A detailed history of Exchange Traded Concepts, LLC transactions in Rhythm Pharmaceuticals, Inc. stock. As of the latest transaction made, Exchange Traded Concepts, LLC holds 11,912 shares of RYTM stock, worth $705,547. This represents 0.01% of its overall portfolio holdings.
Number of Shares
11,912
Previous 12,375
3.74%
Holding current value
$705,547
Previous $691,000
8.83%
% of portfolio
0.01%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding RYTM
# of Institutions
220Shares Held
64.5MCall Options Held
445KPut Options Held
26.6K-
Black Rock Inc. New York, NY6.74MShares$399 Million0.01% of portfolio
-
Primecap Management CO Pasadena, CA6.57MShares$389 Million0.29% of portfolio
-
Ra Capital Management, L.P. Boston, MA6.08MShares$360 Million5.51% of portfolio
-
Baker Bros. Advisors LP New York, NY6.08MShares$360 Million3.77% of portfolio
-
Perceptive Advisors LLC New York, NY3.68MShares$218 Million6.86% of portfolio
About RHYTHM PHARMACEUTICALS, INC.
- Ticker RYTM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,720,000
- Market Cap $3.3B
- Description
- Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the treatment of rare genetic diseases of obesity. The company's lead product candidate is IMCIVREE, a potent melanocortin-4 receptor for the treatment of pro-opiomelanocortin (POMC), proprotein convert...